色狠狠色狠狠综合天天,色香阁综合无码国产在线,丁香婷婷色五月激情综合深爱,天天摸夜夜摸夜夜狠狠摸
Company Profile

Rigen Biotech is a high-tech corporation dedicated to the development, production, sales and testing services of individual molecular diagnosis products. The corporation was founded in August 2017 with 2500 square meters in the Inor Park, Pujiang Town, Minhang District, Shanghai. Moreover, it has a level-10000 clean GMP standard workshop and R&D laboratory, with mature technology platforms such as first-generation sequencing, fluorescent quantitative PCR, digital PCR, next generation sequencing molecular detection, biological information analysis, etc. Through the establishment of ISO13485 quality system and the opening of domestic and international markets, it is expected that Rigen Biotech will be promoted as a famous brand at home and abroad in five to six years.

More
>>
  Better

NMPA approves Rigen-Bio’s disposable thyroid biopsy needle for ma

2022-06-13

Recently, Shanghai Municipal Drug Administration approves Rigen-Bio’s disposable thyroid biopsy needle, which was independently developed and designed for marketing in China. [Registration Certificate No. 20212140622] And filed with the State Drug Administration (NMPA). 

The needle specifically designed for thyroid biopsy is the only product in China to obtain thyroid tissue samples through percutaneous puncture with many advantages , such as easy to operate, and sampling accurately. There are 7 different specifications, 26G, 25G, 24G, 23G, 22G, 21G, 20G for clinical choices.

細針 內容圖2 新600.png

100

Dream building - 2020 Rigen Biotech annual meeting

2020-01-20

Time flies, time changes.In a flash, the busy year of 2019 has passed.With passion and challenges, a brand new 2020 has arrived. On the occasion of farewell to the old and welcome to the new,the Shanghai Rigen Biotech  Annual Meeting will be held on the afternoon of January 10, 2020 at the Bili Palace Hotel.

Mr. Hong Gendong, Chairman of Shanghai Rigen Biotech , Ms. Bao Wenjing, General Manager, company executives and employees of the company gathered together to share the gains and joys of the past year and look forward to a bright future together.

The annual meeting consists of three parts: leaders' speech, excellent commendation and dinner party.

The chairman and general manager gave speeches respectively, affirmed the performance of Shanghai Rigen Biotech in 2019, and clarified the company's overall plan and goals for 2020:

The company's success is inseparable from the joint efforts of every Rigen Bio-Human. This commendation has a special award for best sales performance, best sales management, best sales support, excellent employees and excellent team, which will recognize the employees with outstanding performance in 2019.

The staff of each department presented carefully prepared programs, the opening street dance of the explosion, showing off the whole audience;  Then there were small dramas-dating conferences, series of songs and stand-up crosstalk, which fully demonstrated our talents as Rigen Bio-human.  Finally, the first show brought by Rui Jing Biology Chorus: "Tomorrow will be better".The whole party was brilliant and won applause from the audience. The lottery draw was delighted with music, and the selection of third prize, second prize, first prize, and special prize set off a wave of climax at the annual meeting.

The dinner not only brought cheers and laughter to everyone, but also brought colleagues' hearts closer together. The leaders of the company interacted with the employees affectionately, and the climax of the whole meeting was repeated, showing the joy and harmony of the big family of Rigen Biotech .

In the past year, we have smiled, had a hard time, and have also learned. In the face of 2020, we are full of longing, step by step, and solidly write a brighter future.


Shanghai Rigen Biotechnology Co., Ltd. was approved as a high-tech

2019-12-30

Shanghai Rigen Biotechnology Co., Ltd. was officially recognized as a national high-tech enterprise in December 2019 and became a national high-tech enterprise, enjoying all the preferential policies.

100